Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.66USD
3:32pm EST
Change (% chg)

$0.01 (+0.38%)
Prev Close
$2.65
Open
$2.68
Day's High
$2.68
Day's Low
$2.58
Volume
35,062
Avg. Vol
140,501
52-wk High
$4.60
52-wk Low
$2.24

Chart for

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $95.50
Shares Outstanding(Mil.): 36.04
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 192.73 16.31
EPS (TTM): -- -- --
ROI: -- -0.67 35.74
ROE: -- -3.38 17.71

BRIEF-Ophthotech Q3 earnings per share $5.25

* Ophthotech reports third quarter 2017 financial and operating results

Nov 08 2017

BRIEF-Ophthotech recieves termination notice from Novartis Pharma

* Ophthotech-On oct 24, co received from Novartis Pharma notice terminating Licensing & Commercialization Agreement between parties dated May 19, 2014 Source text : (http://bit.ly/2gPty5O) Further company coverage:

Oct 27 2017

BRIEF-Ophthotech gives update on programs for treatment of eye diseases

* Ophthotech provides update on Zimura® complement programs for treatment of eye diseases

Sep 19 2017

Competitors

Earnings vs. Estimates